semaglutide & tirzepatide weight loss vs. Semaglutide: What's the Difference? Semaglutide vs tirzepatide for weight

The Jorge 2026 study found that GLP-1 receptor agonists were associated with reduced progression of kidney disease in lupus patients, including those with lupus nephritis

Guests: Jennifer Wittwer, endocrinologist at The Christ Hospital Health Network Dave Knapp, founder, On the Pen Select music from Blue Dot Sessions ( www.sessions.blue )

Report Back: After a few weeks on a new schedule, check in with your care team

Aim for a minimum of 80 to 100 ounces of water daily, with an emphasis on increasing intake during the first 48 hours post-injection

Non-Diabetic PAD Patients on GLP-1RAs Show Reduced Risk of Serious Cardiovascular Outcomes Compared to Those Without GLP-1RAs PAD is a condition where the peripheral arteries that carry blood away from the heart to other parts of the body become narrowed or blocked, reducing blood flow to the limbs, often in the legs